✦ LIBER ✦

Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer

✍ Scribed by Andreas Teufel; Silke Steinmann; Jürgen Siebler; Christiane Zanke; Herbert Hohl; Bernd Adami; M Schroeder; O Klein; Thomas Höhler; Peter R Galle; Michael Heike; Markus Moehler

Book ID: 115010566
Publisher: BioMed Central
Year: 2004
Tongue: English
Weight: 301 KB
Volume: 4
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-4-38

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of the folinic acid/5-fluorouracil/i

Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study

✍ Eric François; Jean-François Berdah; Emmanuel Chamorey; Gérard Lesbats; Eric Tei 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 286 KB

Cost-effectiveness analysis of irinoteca

Cost-effectiveness analysis of irinotecan plus fluorouracil/folinic acid compared with fluorouracil/folinic acid alone as first-line treatment for advanced colorectal cancer

✍ Warren Mark Hart; Carlos Rubio-Terrés; Linda Pronk; Svetlana Kobina; Eduardo Día 📂 Article 📅 2003 🏛 Springer Milan 🌐 Spanish ⚖ 188 KB

Oxaliplatin added to the simplified bimo

Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)

✍ F Maindrault-Goebel; C Louvet; T André; E Carola; J.P Lotz; J.L Molitor; M.L Gar 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 141 KB

598 ORAL Randomised comparison of 5-FU/f

598 ORAL Randomised comparison of 5-FU/folinic acid plus irinotecan (FOLFIRI) and irinotecan plus oxaliplatin (IROX) in first-line therapy of metastatic colorectal cancer (CRC): the fire-trial

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Phase III trial of irinotecan plus infus

Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer

✍ Ludwig Fischer von Weikersthal; Andreas Schalhorn; Martina Stauch; Detlef Quietz 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 391 KB

664 PUBLICATION Cetuximab in combination

664 PUBLICATION Cetuximab in combination with irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFIRI) in the first-line treatment of metastatic colorectal cancer (mCRC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 137 KB